acms Weekly Update MultiBriefs
Contact Us
Media Kit

Browse Categories

Browse by Date

Search past issues
Search products and services

A phase 3 trial designed to evaluate SGX301 for treatment of cutaneous T-cell lymphoma met its primary endpoint, according to the agent’s manufacturer. The FLASH trial included 169 patients with early-stage cutaneous T-cell lymphoma, a rare and heterogenous group of...

source: HemOnc Today via Healio

Login to see American College of Mohs Surgery member updates related to the Coronavirus Disease. The ACMS encourages members to monitor the CDC, WHO, JAMA Network , NCCN and AMA for updates related to the COVID-19 pandemic, and to continue to practice and enforce PPE best...


Findings published in JAMA Dermatology suggested that clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot yet be ruled out. However, the researchers...

source: Cancer Network

Sometimes cancer stays put, but often it metastasizes, spreading to new locations in the body. It has long been suspected that genetic mutations arising inside tumor cells drive this potentially devastating turn of events. Now researchers have shown for the first time that...

source: Technology Networks

The danger of skin cancer certainly hasn't disappeared during the age of coronavirus, and using sunscreen is more important than ever, experts say. The only way to safely escape the familiar interiors of our homes during this pandemic is to go outside into the fresh air,...

source: St. Louis Post-Dispatch

Episode 17 of the College’s podcast series is now available at In this latest installment, host Dr. Thomas Knackstedt chats with Murad Alam, MD, MSCI, MBA, FACMS. This conversation centers around his work with Sebaceous carcinoma, and the...



Powered by MultiBriefs
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063

Subscribe to The Cutting Edge

*First Name:
*Last Name:
Street Address:
State / Province:
Zip / Postal Code:
Are you a member of ACMS? Yes   No
Privacy Policy